<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/presentations/presentation-details/2026/Agenus-July-11-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-11-09T04:07:30-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/presentations/presentation-details/2021/Test-Item-Presents-at-JP-Morgan/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-20T12:11:00-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/presentations/presentation-details/2020/Test-Item-Presents-at-Morgan-Stanley-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-20T12:11:00-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/presentations/presentation-details/2020/Test-Item-Presents-at-an-Important-Event/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-20T12:11:00-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Rodman--Renshaw---Virtual-Fireside-Chat--2026-aqoaWzMTQ5/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-11-05T05:03:02-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Agenus-Q3-2026-Earnings-Report-2026-Rh6PlKIEqj/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-10-22T04:30:49-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Chardans-10th-Annual-Healthcare-Investor-Conference-2026-cZpLUlTJcI/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-10-20T11:56:41-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/HC-Wainwright-28th-Annual-Global-Investment-Conference--Fireside-Chat-2026-F47vGjx8VG/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-08-31T07:30:07-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Agenus-Stakeholder-Webcast--September-2026-2026-PlPWwbj6Dj/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-09-11T11:14:41-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Cantor-Global-Healthcare-Conference-2026---Fireside-Chat-2026-A1LqycsE6C/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-09-10T10:16:19-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Agenus-Q2-2026-Earnings-2026-VQZC71HfzZ/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-08-03T12:48:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Agenus-Corporate-Update-2026-DXZ-ruVrCn/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-07-13T05:33:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Agenus-Annual-Virtual-Shareholder-Meeting--2026-2026-R4QfeuJ1YH/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-06-18T10:31:43-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Agenus-Stakeholder-Webcast-March-2026--Access-and-Execution-2026-gFRMbO5QFt/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-03-30T02:42:01-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2026/Agenus-Stakeholder-Webcast-January-2026--Access-to-Acceleration-Agenus-BOTBAL-Global-Momentum-Entering-2026--2026-foKjjimQvM/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-01-30T10:01:48-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2025/Agenus-End-of-Year-2025-Stakeholder-Briefing-Webcast-2025-cali4DwNJa/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-12-10T11:58:18-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2025/Agenus-October-2025-Stakeholder-Briefing-Webcast--Global-Momentum-BOTBAL-Across-Borders-2025-UPqwJmhgtM/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-10-27T04:42:02-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2025/HC-Wainwright-27th-Annual-Global-Investment-Conference--Fireside-Chat-2025-Gs8zj50qIF/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-09-05T09:32:02-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2025/Stakeholder-Webcast-Participation-Details/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-08-28T10:24:00-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2025/Markets-Briefing-on-Agenus-and-Zydus-Strategic-Partnership/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-06-03T07:01:32-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2025/Agenus-First-Quarter-2025-Financial-Results-2025-nDqU26qCcT/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-12T11:38:04-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2025/Agenus-Second-Quarter-2024-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-25T08:35:14-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Agenus-Third-Quarter-2024-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-05T07:31:17-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/STAT-Summit--2024-LioRkSa00L/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-10-29T09:32:28-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/-HC-Wainwright-26th-Annual-Global-Investment-Conference-2024-m9Z18Mw4RL/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-09-03T10:56:41-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Wells-Fargo-2024-Healthcare-Conference-2024-YayrmZoBVh/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-09-03T10:56:42-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Agenus-Second-Quarter-2024-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-07-26T09:20:00-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Goldman-Sachs-45th-Annual-Global-Healthcare-Conference-2024-PF6eBGI42X/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-23T07:30:47-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Agenus-2024-Virtual-Annual-Shareholder-Meeting-2024-R_M91wUSoK/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-04T10:15:25-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Agenus-First-Quarter-2024-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-04-23T12:14:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Agenus-Fourth-Quarter-and-Year-End-2023-Financial-Results-2024-MF8gVTR-BS/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-29T07:30:28-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Leerink-Partners-Global-Biopharma-Conference-2024-ZzA5RLtqIU/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-26T10:46:45-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference-2024-G6zakajBLZ/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-31T07:30:41-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2024/B-Riley-Healthcare-Conference-2024-2X0P_tO8Vh/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-22T01:44:47-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Agenus-Third-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-07T07:00:00-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Corporate-Event-at-ESMO-2023-2023-C5934xM5_9/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-25T05:23:36-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Agenus-Endpoints-Webinar-2023-aV9NJuKmW8/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-12T05:19:36-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/HC-Wainwright-25th-Annual-Global-Investment-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-28T05:05:57-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Baird-2023-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-28T05:05:57-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/2023-Wells-Fargo-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-28T05:05:57-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/BTIG-Virtual-Biotechnology-Conference-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Annual-Shareholders-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Jefferies-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Agenus-First-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/HC-Wainwright-BioConnect-Investor-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Biotech-2050-Podcast--Leadership-in-Revolutionizing-Cancer-Immunotherapy-Garo-Armen-PhD-Chairman--CEO-Agenus/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Agenus-Fourth-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/SVB-Securities-Global-Biopharma-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/Guggenheim-5th-Annual-Oncology-Day/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2023/B-Riley-Securities-2023-Virtual-Oncology-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/5th-Annual-Evercore-ISI-HealthCONx-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/The-Road-Taken--an-Agenus-RD-Event/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/Agenus-Third-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/Agenus-Second-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/William-Blairs-Biotech-Focus-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/Agenus-ESMO-GI-Webcast-on-BotensilimabBalstilimab-in-MSS-CRC/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/Jefferies-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/Virtual-Annual-Shareholders-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/Agenus-First-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/2022-AACR-Annual-Meeting--AGEN1571-Preclinical-Data/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/Agenus-Fourth-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/B-Riley-Securities-2022-Virtual-Oncology-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2022/HC-Wainwright-BIOCONNECT-Virtual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/4th-Annual-Evercore-ISI-HealthCONx-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Fireside-Chat-at-the-B-Riley-Fall-2021-Growth-Biotech-Best-Ideas-Series/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/William-Blair---Discuss-AGEN1181-Clinical-Data-from-SITC-2021-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/2021-SITC-Annual-Meeting--AGEN1181-Phase-1-Clinical-Data/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Agenus-Third-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Agenus-Business-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/ESMO-2021---Agenus-Presents-Updates-on-Balstilimab-Plus-Zalifrelimab-Combination/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Baird-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/HC-Wainwright-23rd-Annual-Global-Investment-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/BTIG-Biotechnology-Conference-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Agenus-Second-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/William-Blair-Biotech-Focus-Conference-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/The-TIGIT-Pathway-A-Deep-Dive-in-Cancer-Immunotherapy-Targets/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Virtual-Raymond-James-Human-Health-Innovations-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Gilead-Oncology-Week-hosted-by-RBC-Capital-Markets/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Virtual-Annual-Shareholders-Meeting-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Jefferies-Virtual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/2021-ASCO-Annual-Meeting---Presentations-on-balstilimab-differentiation-and-AGEN2373/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Agenus-to-Host-Conference-Call-to-Discuss-Global-Licensing-Agreement-with-Bristol-Myers-Squibb-for-Agenus-Anti-TIGIT-Bispecific-Antibody-Program/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Agenus-First-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Dr-Steven-ODay-Participates-in-World-Vaccine-Congress-Washington-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Webcast-Hosted-by-William-Blair-on-AGEN1181-and-Balstilimab-AACR-Presentations/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/AACR-2021---Preclinical-and-Clinical-Presentations-on-AGEN1181/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/SGO-2021---Dr-David-OMalley-Presents-on-RaPiDS-Trial-Design/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Agenus-Fourth-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/CAR-TCR-Europe-Providing-Mechanistic-Rationale-for-Combination-Therapies-Through-Functional-Characterisation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/Agenus-Insights-S1E1-Optimally-Targeting-TIGIT---Virtual-RD-Miniseries/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/KOL-Discussion-Select-Targets-and-Modalities-Driving-the-Next-Wave-of-Translational-Immunotherapy-Innovation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2021/B-Riley-Securities-Oncology-Investor-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Evercore-ISI-3rd-Annual-HealthCONx-Virtual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Jefferies-Virtual-London-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Agenus-and-Dr-Steven-ODay-Discuss-AGEN1181-and-SITC-Data-in-Webcast-Hosted-by-William-Blair/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Agenus-and-Dr-Steven-ODay-Participate-in-B-Riley-SITC-2020-Immuno-Oncology-Virtual-Panel/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/SITC-2020---Agenus-Presents-7-Novel-Programs/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Agenus-Third-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/TIGIT-Therapies-Digital-Summit/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Agenus-Discussion-with-Dr-David-OMalley-and-William-Blair-on-ESMO-Presentation-of-Balstilimab-plus-Zalifrelimab-in-Cervical-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/ESMO-2020-Presentation-of-Single-agent-Anti-PD-1-Balstilimab-or-in-Combination-with-Anti-CTLA-4-Zalifrelimab-for-Recurrent-Metastatic-R-M-Cervical-Cancer-CC/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Dr-Jennifer-Buell-Speaks-Live-at-Scientific-American-Inaugural-Fireside-Chat-Series-18-Minutes-With-Hosted-by-Jeremy-Abbate/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T04:06:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Second-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/William-Blair-Biotech-Focus-2020-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/B-Riley-FBR-Virtual-Infectious-Disease-Summit/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Raymond-James-Virtual-Human-Health-Innovation-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Virtual-Annual-Shareholders-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/ASCO-Update-Next-Generation-Immunetherapy-call-with-Drs-Steven-ODay-Chuck-Drake-and-Jennifer-Buell/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/First-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Fourth-Quarter-and-Full-Year-2019-Financial-Results-with-Business-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2020/Investor-Day-New-York-City/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/Agenus-RD-Day-New-York-City/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/Third-Quarter-2019-Financial-Results-with-Business-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/2019-Cantor-Fitzgerald-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/Second-Quarter-2019-Financial-Results-and-Business-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/Agenus-Annual-Shareholders-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/First-Quarter-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/Fourth-Quarter-and-Full-Year-2018-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/Biotech-Electronic-Security-Token-BEST--Key-Information/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/Agenus-Biotech-Electronic-Security-Token-BEST-Launch/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2019/Biotech-Electronic-Security-Token-BEST-FAQs/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Gilead-and-Agenus-Enter-Into-Collaboration-To-Develop-Immuno-Oncology-Therapies/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Agenus-Statement/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/2018-Jefferies-London-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Agenus-Third-Quarter-2018-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Immune-Checkpoint-Inhibitors-Response-Rates-in-Solid-Tumors-Agenus-Slide/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/2018-Cantor-Fitzgerald-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Agenus-Second-Quarter-2018-Financial-Results-and-Corporate-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Agenus-News-Brief-Forward-Looking-Statements/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Agenus-2018-Annual-Meeting-of-Stockholders/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Jefferies-2018-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Deutsche-Banks-43rd-Annual-Health-Care-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Agenus-First-Quarter-2018-Financial-Results-and-Corporate-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Jefferies-IO-Cell-Therapy-Summit/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2018/Fourth-Quarter-and-Full-Year-2017-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2017/Jefferies-2017-London-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2017/Agenus-Third-Quarter-2017-Earnings-Call/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2017/Ladenburg-Thalmann-2017-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2017/Cantor-Fitzgerald-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2017/Agenus-2nd-Quarter-2017-Earnings-Call/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2017/Agenus-2017-Annual-Meeting-of-Stockholders/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2017/Jefferies-2017-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/event-details/2017/Agenus-Investor-Presentation-June-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T11:28:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-More-Than-Half-of-Patients-with-Refractory-MSS-Metastatic-Colorectal-Cancer-Achieved-Long-Term-Survival-Following-BOTBAL-Treatment-at-SITC-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-11-06T09:00:13-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-Third-Quarter-2026-Results-Highlighted-by-First-Marketing-Authorizations-for-BOTBAL-and-Global-Investigator-Support-for-Phase-3-ROBBIN-Study/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-11-05T07:34:53-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Participate-in-Rodman--Renshaw-Virtual-Fireside-Chat/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-11-02T06:05:03-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Nature-Medicine-Publication-of-Multicenter-UNICORN-Phase-2-Trial-Demonstrating-Deep-Responses-with-Neoadjuvant-BOTBAL-in-Resectable-Colon-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-11-02T06:43:05-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-72-of-Patients-with-Locally-Advanced-dMMR-Colon-Cancer-Had-No-Cancer-Remaining-at-Surgery-Following-Six-Weeks-of-BOTBAL-in-Phase-2-NEOASIS-Study-at-ESMO-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-10-25T07:00:26-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Provide-Third-Quarter-2026-Financial-Report-and-Development-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-10-22T04:30:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Participate-in-Chardans-10th-Annual-Healthcare-Investor-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-10-09T03:23:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Armenia-Grants-First-Marketing-Authorizations-for-Agenus-BOTBAL-in-Previously-Treated-MSS-Metastatic-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-10-15T11:19:36-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-48-Estimated-Three-Year-Survival-With-BOTBAL-in-Recurrent-Ovarian-Cancer-at-IGCS-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-10-03T10:50:28-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Present-BOTBAL-Long-Term-Survival-Data-and-Translational-Research-With-agenT-797-in-Colorectal-Cancer-at-SITC-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-10-02T10:56:14-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Present-Three-Year-Overall-Survival-Data-for-BOTBAL-in-Recurrent-Ovarian-Cancer-at-IGCS-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-09-10T07:30:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Participate-in-Upcoming-September-Investor-Conferences/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-08-31T07:30:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Peer-Reviewed-Publication-Linking-BOTBALs-Durable-Survival-in-MSS-Metastatic-Colorectal-Cancer-to-Its-Distinct-Immune-Priming-Mechanism/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-08-28T10:07:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Updated-NEST-Phase-2-Publication-Reporting-Deep-Pathologic-Responses-and-No-Observed-Recurrences-with-Neoadjuvant-BOTBAL-in-Resectable-Colon-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-09-01T04:29:25-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-Second-Quarter-2026-Results-and-Advances-Phase-3-ROBBIN-Trial-of-BOTBAL-in-Neoadjuvant-MSS-Colon-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-08-06T07:30:18-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Provide-Second-Quarter-2026-Financial-Report-and-Development-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-07-28T04:30:04-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Three-BOTBAL-Presentations-Spanning-Neoadjuvant-and-Late-Line-Colorectal-Cancer-and-Advanced-Sarcomas-at-ESMO-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-07-17T10:28:05-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Oversubscribed-Private-Placement-of-Up-to-340-Million-to-Advance-Registrational-ROBBIN-Trial-of-Neoadjuvant-BOTBAL-in-MSS-Colon-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-07-13T06:00:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-Landmark-BOTBAL-Data-Showing-33-Three-Year-Overall-Survival-in-Refractory-MSS-Metastatic-Colorectal-Cancer-Without-Active-Liver-Metastases-at-ESMO-GI-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-07-06T07:30:21-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Three-Year-Survival-Data-from-Phase-1b-BOTBAL-Study-in-MSS-Metastatic-Colorectal-Cancer-to-be-Presented-at-ESMO-GI-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-06-25T07:00:14-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Virtual-2026-Annual-Shareholders-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-06-02T04:30:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-and-Noetik-Present-ASCO-2026-Data-Linking-AI-Analysis-of-Routine-Pretreatment-Tumor-Pathology-Images-to-Response-and-Survival-with-BOTBAL-in-MSS-Metastatic-CRC/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-05-21T05:00:17-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Presents-Phase-2-BOTBAL-Melanoma-Data-Showing-Durable-Responses-and-Meaningful-Survival-in-Advanced-Checkpoint-Refractory-Melanoma-at-ASCO-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-05-21T05:00:25-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Publication-of-Phase-1b-Botensilimab-and-Balstilimab-Data-in-Post-Immunotherapy-Hepatocellular-Carcinoma-in-Liver-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-05-15T04:11:08-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-First-Quarter-2026-Financial-Results-and-Highlights-BOTBAL-Execution-Across-Global-Access-and-Phase-3-Development/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-05-11T08:45:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Provide-First-Quarter-2026-Financial-Report-and-Corporate-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-05-04T04:30:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Present-First-Phase-2-Botensilimab-Data-in-Advanced-Cutaneous-Melanoma-at-ASCO-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-04-21T10:00:17-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Names-BAP-Pharma-as-Exclusive-Global-Partner-for-BOTBAL-Access-Programs/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-04-21T08:00:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-Phase-II-Data-Demonstrating-Immune-Reprogramming-and-Durable-Survival-with-Botensilimab-Balstilimab-and-agenT-797-in-PD-1-Refractory-Gastroesophageal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-04-17T04:43:05-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Data-from-Phase-II-Study-of-BOTBAL-in-Combination-with-agent-797-in-PD-1-Refractory-Gastroesophageal-Cancer-to-be-Presented-at-AACR-2026/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-04-03T07:30:28-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-First-Patient-Enrolled-in-Global-Phase-3-BATTMAN-Trial-of-BOTBAL-Immunotherapy-Combination-in-MSS-or-pMMR-Metastatic-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-04-01T07:30:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Host-March-2026-Stakeholder-Webcast-Harnessing-the-Immune-System-to-Advance-BOT--BAL-Across-Tumor-Types-and-Expand-Patient-Access/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-03-26T04:53:16-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Upcoming-AACR-2026-Presentation-Evaluating-Botensilimab-Plus-Balstilimab-in-First-Line-MSS-Metastatic-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-03-17T04:40:07-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Reports-2025-Results-BOTBAL-Advances-to-Phase-3-and-Early-Access-Programs-Expand-Globally-with-Initial-Revenues-Recognized/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-03-16T07:30:23-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Triggers-First-20M-Contingent-Payment-Under-Zydus-Life-Sciences-Collaboration-to-Support-BOTBAL-Manufacturing-Needs/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-03-10T07:30:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Provide-Fourth-Quarter-and-Year-end-2025-Financial-Report-and-Corporate-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-03-04T04:30:15-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Presents-Biomarker-Data-Demonstrating-Survival-Stratification-in-MSS-mCRC-and-Other-Immunologically-Cold-Tumors-Treated-with-BOTBAL/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-02-19T03:15:12-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Present-New-Data-at-AACR-IO-Exploring-Systemic-and-Tumor-Inflammation-Biomarkers-with-BOTBAL-in-Immunologically-Cold-Tumors/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-02-09T01:00:25-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Expands-Medical-Affairs-Infrastructure-to-Support-Increasing-Physician-Requests-for-Authorized-Access-to-Botensilimab-Plus-Balstilimab/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-01-21T07:30:33-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-to-Host-First-2026-Stakeholder-Webcast/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-01-20T06:24:12-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/Agenus-Announces-Closing-of-141M-Strategic-Collaboration-with-Zydus-Lifesciences-to-Advance-BOTBAL-and-Strengthen-U-S--Manufacturing-Readiness/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-01-15T07:01:43-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2026/France-Expands-National-AAC-Access-for-Agenus-Botensilimab--Balstilimab-for-Ovarian-Cancer-and-Soft-Tissue-Sarcomas/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-01-12T07:30:36-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Reports-Deep-Durable-Responses-with-Botensilimab--Balstilimab-in-Highly-Refractory-Ovarian-Cancer-Published-in-JITC/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-12-23T08:05:09-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Host-End-of-Year-Stakeholder-Webcast-Featuring-GI-Oncology-Leaders-and-Progress-of-BOTBAL/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-11-19T04:01:08-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Appoints-Dr--Jos-Iglesias-as-Chief-Medical-Affairs-Officer-to-Guide-Global-Medical-Affairs-and-Early-Access-Programs-Including-Frances-AAC/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-11-18T08:41:08-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Reports-Q3-2025-Results-Showcasing-Clinical-and-Regulatory-Advances/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-11-10T09:33:59-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Provide-Corporate-Update-and-Third-Quarter-2025-Financial-Report/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-11-05T01:47:18-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Reports-39-of-Patients-Alive-at-Two-Years-with-BOTBAL-Across-Multiple-Refractory-Solid-Tumors-at-ESMO-2025/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-10-17T08:00:46-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Host-October-Stakeholder-Briefing-Showcasing-BOTBAL-Global-Momentum-and-Post-ESMO-Insights/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-10-16T07:48:23-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/France-Grants-Reimbursed-Compassionate-Access-AAC-for-Agenus-BOTBAL-in-Refractory-MSS-Metastatic-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-09-09T07:43:17-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Participate-in-the-H-C--Wainwright-27th-Annual-Global-Investment-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-09-05T08:52:25-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Update-Agenus-Aug-27-Stakeholder-WebcastTransformative-IO-Updates-BOTBAL-Data-BATTMAN-Preview-Zydus-Partnership-Momentum-and-MiNK-Spotlight/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-08-26T09:37:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Unveil-BOTBAL-Strategic-Advancements-Key-Milestones-and-Future-Outlook-in-Virtual-Stakeholder-Briefing-on-August-27-2025/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-08-19T07:30:32-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Announces-Second-Quarter-2025-Financial-Results-and-Virtual-Meeting-to-Discuss-Strategic-Progress/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-08-11T08:27:08-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Provide-Corporate-Update-and-Second-Quarter-2025-Financial-Report/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-07-31T07:30:30-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Highlight-Emerging-Survival-Plateaus-with-BotensilimabBalstilimab-in-Oral-Presentation-of-Study-in-Refractory-Patients-Across-Five-Tumor-Types-at-ESMO-2025/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-07-25T12:46:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-BOTBAL-Achieves-42-Two-Year-Survival-in-Refractory-MSS-CRC-Advances-Toward-Registration-with-FDA-Alignment-on-Phase-3/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-07-07T08:55:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-and-Noetik-Enter-Collaboration-to-Develop-AI-Enabled-Predictive-Biomarkers-for-BOTBAL-Using-Foundation-Models-of-Virtual-Cell-Biology/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-06-17T07:30:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Announces-Virtual-Annual-Shareholders-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-06-10T01:30:29-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-and-Zydus-Lifesciences-Enter-141M-Strategic-Collaboration-to-Advance-BOTBAL-Expand-Zydus-Biologics-Manufacturing-in-the-US/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-06-03T07:00:42-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Presents-New-Data-at-ASCO-Highlighting-Botensilimabs-Immune-Activation-in-MSS-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-30T07:30:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Announces-New-Data-from-Expanded-MSS-Metastatic-Colorectal-Cancer-Cohort-to-be-Presented-at-ESMO-GI-2025/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-15T10:40:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Reports-Q1-2025-Financial-Results-and-Key-Business-Updates/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-17T04:36:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Renowned-GI-Oncology-Leader-Dr--Richard-Goldberg-Joins-Agenus-as-Chief-Development-Officer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-12T07:20:10-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Provide-Corporate-Update-and-First-Quarter-2025-Financial-Report/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-04-29T07:30:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-BOTBAL-Neoadjuvant-Pan-Cancer-Data-from-the-NEOASIS-Study-Presented-in-an-Oral-Session-at-AACR/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-04-28T03:30:16-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-BOTBAL-Data-in-Pretreated-Liver-Cancer-Presented-at-AACR-2025/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-04-28T03:17:41-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Announces-Botensilimab-and-Balstilimab-Presentations-at-ASCO-2025/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-04-23T12:05:08-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Present-New-BOTBAL-Data-in-Two-Presentations-at-AACR-2025/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-03-25T04:40:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Unveils-Colorectal-Cancer-Survey-Findings-Highlighting-the-Urgent-Need-for-Treatment-Innovation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-03-19T07:30:29-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Reports-Q4-and-Year-End-2024-Results-Strategic-Operational-Improvements-and-Significant-Cost-Reductions-Enhance-Sustainability-of-Promising-BOTBAL-Program/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-17T04:36:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Reports-Impact-of-Key-Immuno-Oncology-Data-Presented-at-Leading-Medical-Conferences-and-Peer-Reviewed-Publications/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-26T04:48:08-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Participate-in-B.-Riley-Securities-Precision-Oncology--Radiopharma-Investor-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-25T02:30:29-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-to-Provide-Corporate-Update-and-Fourth-Quarter--Full-Year-2024-Financial-Report/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-25T08:26:07-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Presents-New-BotensilimabBalstilimab-Data-in-Gastric-Cancer-at-AACR-IO-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-24T08:33:07-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/CORRECTING-and-REPLACING-Agenus-BOTBAL-Selected-for-Two-Presentations-at-Upcoming-AACR-IO-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-23T07:38:26-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-BOTBAL-Selected-for-Two-Presentations-at-Upcoming-AACR-IO-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-23T05:24:59-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Announces-Publication-in-the-Journal-of-Clinical-Oncology-Highlighting-Data-from-Botensilimab-Plus-Balstilimab-in-RelapsedRefractory-Metastatic-Sarcomas/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-01-29T12:37:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2025/Agenus-Presents-Data-at-ASCO-GI-Demonstrating-Impact-of-BOTBAL-in-Colorectal-Cancer-Across-Neoadjuvant-and-Advanced-Disease/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-19T09:05:46-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-Five-Presentations-at-ASCO-GI-Highlighting-BOTBAL-Activity-Across-Colorectal-and-Gastric-Cancers/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-18T07:30:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-Strategic-Realignment-to-Focus-on-Core-Programs-and-Significantly-Reduce-Costs/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T07:30:38-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Secures-22-Million-Mortgage-and-Announces-Strategic-Operational-Realignment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-27T08:15:15-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Reports-Third-Quarter-2024-Financial-Results-and-Strategic-Advancements-in-BOTBAL-Development/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-17T04:36:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Present-Compelling-Data-on-Botensilimab-and-AGEN1721-at-SITC-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-07T10:00:34-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Provide-Third-Quarter-2024-Financial-Report-and-Corporate-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-05T07:30:22-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/BotensilimabBalstilimab-Clinical-Responses-in-Refractory-Sarcomas-Presented-at-ESMO-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-09-13T10:00:21-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/BotensilimabBalstilimab-Clinical-Activity-in-Refractory-Sarcomas-to-be-Presented-in-Oral-Session-at-ESMO-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-09-09T07:30:33-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Participate-in-September-Investor-Conferences/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-09-03T07:30:30-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-Appointment-of-Tom-Harrison-to-Board-of-Directors/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-08-08T07:01:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Reports-Second-Quarter-2024-Operational-and-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-17T04:36:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Publishes-Seminal-Study-on-Botensilimabs-Activity-in-Treatment-Resistant-Cancers/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-08-07T10:58:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Provide-Second-Quarter-2024-Financial-Report-and-Corporate-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-07-26T07:00:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-End-of-Phase-2-Meeting-Outcomes-and-Topline-Interim-Phase-2-Data-for-BOTBAL-in-MSS-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-07-18T07:00:43-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Significant-Tumor-Reductions-in-Neoadjuvant-MSS-Colon-Cancer-Patients-Treated-with-BotensilimabBalstilimab-Presented-at-ESMO-GI-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-28T11:10:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Cancer-Therapy-Evaluation-Program-Announces-Availability-of-Botensilimab-for-Clinical-Studies/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-27T07:30:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-Appointment-of-Dr.-Jennifer-Buell-to-Its-Board-of-Directors/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-17T07:00:21-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Nature-Medicine-Reports-Agenus-Novel-Immunotherapy-Demonstrates-Clinical-Activity-Against-a-Deadly-Form-of-Colorectal-Cancer-on-the-Rise-in-Americans-Under-50/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-13T05:15:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-Virtual-Annual-Shareholders-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-04T07:30:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4-32b9c7205/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-24T05:00:25-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Breakthrough-Data-on-BotensilimabBalstilimab-in-MSS-CRC-Presented-at-the-2024-ASCO-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-23T05:10:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Participate-in-Goldman-Sachs-45th-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-23T07:30:21-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/FDA-Grants-Agenus-Type-B-End-of-Phase-2-Meeting-to-Discuss-BOTBAL-Therapy-for-Relapsed-or-Refractory-Metastatic-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-16T07:30:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Reports-First-Quarter-2024-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-17T04:36:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Ligand-and-Agenus-Enter-Into-100-Million-Royalty-Financing-Agreement-2024-1UFqFumAqe/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-08T01:18:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-01T07:30:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/BotensilimabBalstilimab-Data-in-MSS-CRC-Selected-for-the-American-Society-of-Clinical-Oncology-2024-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-04-24T10:00:23-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Provide-First-Quarter-2024-Financial-Report-and-Corporate-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-10T10:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-Updated-Phase-1-Data-and-Progress-on-BOTBAL-Development-in-Metastatic-MSS-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-04-12T07:30:13-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-Reverse-Stock-Split-of-Common-Stock/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-04-05T04:30:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Reports-Fourth-Quarter-and-Full-Year-2023-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-05-17T04:36:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Announces-Preclinical-Data-on-BMS-986442-AGEN1777-at-AACR-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-03-06T07:30:21-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4-078299ec9/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-03-05T04:30:19-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Provide-Corporate-Update-and-Fourth-Quarter--Full-Year-2023-Financial-Report/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-29T07:30:12-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Participate-in-Leerink-Partners-Global-Biopharma-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-26T10:42:36-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Participate-in-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-31T07:30:20-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/BotensilimabBalstilimab-Breakthrough-Data-Presented-at-ASCO-GI-Shows-Unprecedented-Tumor-Shrinkage-and-Robust-Biomarker-Response-in-Prevalent-Colorectal-Cancer-Population/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-22T10:57:14-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-05T04:30:20-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2024/Agenus-to-Participate-in-B.-Riley-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-04T07:30:18-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/BotensilimabBalstilimab-Data-in-Neoadjuvant-Colorectal-Cancer-Selected-for-ASCO-GI-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-12-20T09:42:15-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Receive-25-Million-Milestone-Payment-from-Bristol-Myers-Squibb-for-TIGIT-CD96-Bispecific-Program/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-12-11T07:30:08-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Reports-Third-Quarter-2023-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-10T10:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Provide-Third-Quarter-2023-Financial-Report-and-Corporate-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-26T11:46:49-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Unveils-New-and-Updated-Botensilimab-Data-in-Colorectal-Pancreatic-Lung-Melanoma-and-Sarcoma/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-22T12:00:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/ESMO-2023-Agenus-BotensilimabBalstilimab-Combination-Delivers-Durable-Responses-across-Multiple-Sarcoma-Subtypes/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-21T04:15:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Completes-Enrollment-in-Randomized-Phase-2-Clinical-Trial-of-BotensilimabBalstilimab-in-Advanced-Colorectal-Cancer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-10T07:30:23-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-To-Host-BOTBAL-Program-Update-at-ESMO-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-05T07:30:13-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-09-01T04:30:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Participate-in-September-Investor-Conferences/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-28T05:07:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Prioritizes-Resources-to-Accelerate-Registration-and-Commercialization-of-BOTBAL-Program-in-Multiple-Cancers/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-28T05:09:25-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Reports-Second-Quarter-2023-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-10T10:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Botensilimab-Balstilimab-Data-Update-in-Sarcomas-Selected-for-Oral-Presentation-at-ESMO-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-03T05:06:14-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Provide-Second-Quarter-2023-Financial-Report-and-Corporate-Update-07-26-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Expands-Executive-Leadership-Team-07-20-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/ESMO-GI-Data-Agenus-BotensilimabBalstilimab-Combination-Achieves-Unprecedented-Survival-in-Advanced-Colorectal-Cancer-06-30-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Presents-Positive-Efficacy-and-Safety-Outcomes-for-AGEN2373-at-ASCO-06-05-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Announces-Virtual-Annual-Shareholders-Meeting-06-05-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Participate-in-Jefferies-Healthcare-Conference-05-25-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Provides-Corporate-Update-and-First-Quarter-2023-Financial-Results-05-09-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-10T10:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Selected-for-Late-Breaking-Oral-Presentation-at-ESMO-GI-05-03-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Present-at-the-American-Society-of-Clinical-Oncology-2023-Annual-Meeting-04-26-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Provide-Corporate-Update-and-First-Quarter-2023-Financial-Report-04-25-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Participate-in-May-Investor-Conferences-04-24-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Receives-Fast-Track-Designation-for-Botensilimab-and-Balstilimab-in-Colorectal-Cancer-04-17-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Announces-Dividend-of-5-Million-Shares-of-MiNK-Therapeutics-03-30-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Botensilimab-in-Combination-with-Balstilimab-Shows-33-Durable-Responses-in-Ovarian-Cancer-03-27-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Outlines-2023-Objectives-03-14-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-10T10:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Cancels-Conference-Call-to-Discuss-the-Companys-Minority-Cash-Holdings-at-SVB-in-Light-of-Governments-SVB-Deposit-Access-Announcement-03-12-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Schedules-Conference-Call-to-Discuss-the-Companys-Minority-Cash-Holdings-at-SVB-03-11-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Provide-Corporate-Update-and-Fourth-Quarter-Full-Year-2022-Financial-Report-02-28-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Present-Botensilimab-Data-in-Oral-Plenary-Session-at-the-Society-of-Gynecologic-Oncology-2023-Annual-Meeting-on-Womens-Cancer-02-28-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Participate-in-February-Investor-Conferences-01-26-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-Presents-Clinical-Data-Demonstrating-Durable-Responses-of-BotensilimabBalstilimab-Combination-in-Metastatic-Microsatellite-Stable-Colorectal-Cancer-at-ASCO-GI-01-23-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2023/Agenus-to-Participate-at-B-Riley-Securities-2023-Virtual-Oncology-Conference-01-10-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Present-Botensilimab-Data-at-Late-Breaking-Oral-Session-at-ASCO-GI-12-21-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Data-at-CTOS-2022-Highlight-Durable-Clinical-Responses-of-Botensilimab--Balstilimab-Combination-in-Advanced-Sarcoma-11-17-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Participate-at-5th-Annual-Evercore-ISI-HealthCONx-Conference-11-16-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Data-at-SITC-2022-Highlight-Durable-Responses-of-Botensilimab--Balstilimab-Combination-in-Nine-Different-Treatment-Resistant-Cancers-11-14-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Provides-Corporate-Update-and-Third-Quarter-2022-Financial-Report-11-08-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-10T10:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Provide-Corporate-Update-and-Third-Quarter-2022-Financial-Report-10-25-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/GSKs-older-adult-RSV-vaccine-candidate-containing-Agenus-QS-21-STIMULON-shows-94.1-reduction-in-severe-RSV-disease-and-overall-vaccine-efficacy-of-82.6-in-pivotal-trial-10-13-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/VBI-Vaccines-and-Agenus-Announce-Collaboration-to-Evaluate-VBI-1901-in-Combination-with-Anti-PD-1-Balstilimab-in-a-Phase-2-Study-in-Primary-Glioblastoma-Patients-10-12-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Host-The-Road-Taken-RD-Event-on-November-12-2022-10-05-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Present-Botensilimab-Data-at-a-Plenary-Session-of-the-Society-for-Immunotherapy-of-Cancer-SITC-37th-Annual-Meeting-10-05-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Makes-Senior-Regulatory-and-Clinical-Appointments-09-12-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Initiates-Botensilimab-Phase-2-ACTIVATE-Trials-in-Advanced-MSS-Colorectal-Cancer-and-Advanced-Melanoma-09-12-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Provides-Corporate-Update-and-Second-Quarter-2022-Financial-Report-08-09-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-10T10:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Participate-at-BTIG-Biotechnology-Conference-08-02-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Announces-First-Patient-Dosed-in-Phase-1-Study-of-AGEN1571-anti-ILT2-in-Advanced-Solid-Tumors-08-01-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Provide-Corporate-Update-and-Second-Quarter-2022-Financial-Report-07-27-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Participate-at-William-Blairs-Biotech-Focus-Conference-06-30-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Shows-Unprecedented-Activity-for-BotensilimabBalstilimab-Combination-in-Microsatellite-Stable-Colorectal-Cancer-at-ESMO-World-GI-Congress-06-29-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Host-Investor-Webcast-to-Review-Late-Breaking-Botensilimab-and-Balstilimab-Data-Presented-at-ESMO-World-GI-Congress-06-21-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/GSKs-RSV-vaccine-candidate-for-older-adults-containing-Agenus-QS-21-STIMULON-as-part-of-GSKs-AS01-adjuvant-reports-positive-pivotal-data-supporting-initiation-of-global-regulatory-submissions-06-10-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Advances-Portfolio-with-6-Clinical-Collaborations-05-31-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Announces-Virtual-Annual-Shareholders-Meeting-05-25-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Participate-at-Jefferies-Healthcare-Conference-05-25-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Announces-Late-Breaking-Oral-Presentation-at-ESMO-GI-and-Strategies-to-Advance-Botensilimab-05-24-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Corporate-Update-and-First-Quarter-2022-Financial-Report-05-10-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-10T10:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Provide-Corporate-Update-and-First-Quarter-2022-Financial-Report-04-26-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Presents-Data-on-AGEN1571-anti-ILT2-at-AACR-and-Announces-IND-Clearance-04-08-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-CD137-Agonist-AGEN2373-Advances-in-the-Clinic-Triggering-Milestone-Payment-from-Gilead-04-05-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Targovax-ASA-and-Agenus-announce-collaboration-on-mutant-KRAS-cancer-vaccine-adjuvanted-with-QS-21-STIMULON-03-07-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-Corporate-Update-and-Fourth-Quarter-Full-Year-2021-Financial-Report-03-01-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Provide-Corporate-Update-and-Fourth-Quarter-Full-Year-2021-Financial-Report-02-15-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2022/Agenus-to-Participate-at-Upcoming-Investor-Conferences-01-05-2022/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Balstilimab-Plus-Zalifrelimab-Data-Published-in-Journal-of-Clinical-Oncology-JCO-12-22-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-4th-Annual-Evercore-ISI-HealthCONx-Conference-11-17-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Clinical-Activity-of-AGEN1181-Demonstrated-Across-Nine-Treatment-Resistant-Cancers-at-SITC-11-12-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Corporate-Update-and-Third-Quarter-2021-Financial-Report-11-09-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-Fireside-Chat-at-the-B.-Riley-Fall-2021-Growth-Biotech-Best-Ideas-Series-11-09-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-Webcast-Hosted-by-William-Blair-to-Discuss-AGEN1181-Clinical-Data-from-SITC-2021-Meeting-11-04-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Provide-Corporate-Update-and-Third-Quarter-2021-Financial-Report-10-25-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Provides-Update-on-Balstilimab-Development-10-22-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Receive-20M-Milestone-Payment-from-Bristol-Myers-Squibb-with-Dosing-of-First-Patient-with-its-TIGIT-Bispecific-Antibody-10-12-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Present-AGEN1181-Clinical-Data-at-SITC-10-01-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Combination-of-Balstilimab-Plus-Zalifrelimab-Doubles-Responses-in-2L-Cervical-Cancer-in-Data-to-Be-Presented-at-ESMO-09-16-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/New-Agenus-Subsidiary-SaponiQx-Builds-Innovative-Adjuvant-Platform-and-Forms-Collaboration-with-Ginkgo-Bioworks-09-10-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-September-Investor-Conferences-09-09-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Balstilimab-Monotherapy-Data-Published-in-Gynecologic-Oncology-08-26-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Corporate-Update-and-Second-Quarter-2021-Financial-Report-08-09-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-the-BTIG-Virtual-Biotechnology-Conference-2021-08-02-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/MiNK-Therapeutics-Announces-Confidential-Submission-of-Draft-Registration-Statement-for-Proposed-Initial-Public-Offering-07-28-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Provide-Corporate-Update-and-Second-Quarter-2021-Financial-Report-07-26-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-Resistance-Focused-Oncology-Panel-at-the-William-Blair-Biotech-Focus-Conference-2021-07-07-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Closes-200M-Upfront-BMS-Collaboration-and-Announces-FDA-Acceptance-of-IND-for-Partnered-Anti-TIGIT-Bispecific-Antibody-AGEN1777-07-06-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-the-Raymond-James-2021-Human-Health-Innovation-Conference-06-21-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Announces-U.S.-FDA-Acceptance-and-Priority-Review-of-Balstilimab-Biologics-License-Application-for-the-Treatment-of-Recurrent-or-Metastatic-Cervical-Cancer-06-17-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Announces-Virtual-Annual-Shareholders-Meeting-06-15-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Presentations-at-ASCO-2021-Demonstrate-Differentiated-Activity-of-Balstilimab-and-Provide-Clinical-Update-on-AGEN2373-06-04-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-Fireside-Chat-at-the-Jefferies-2021-Virtual-Healthcare-Conference-06-01-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Presents-New-Data-on-Balstilimab-and-AGEN2373-in-ASCO-Abstracts-05-20-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Host-Conference-Call-to-Discuss-Global-Licensing-Agreement-with-Bristol-Myers-Squibb-for-Agenus-Anti-TIGIT-Bispecific-Antibody-Program-05-18-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-and-Bristol-Myers-Squibb-Announce-Exclusive-Global-License-for-Agenus-Anti-TIGIT-Bispecific-Antibody-Program-05-18-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Corporate-Update-and-First-Quarter-2021-Financial-Report-05-06-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Present-at-the-2021-ASCO-Annual-Meeting-04-28-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Provide-Corporate-Update-and-First-Quarter-2021-Financial-Report-04-22-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Submits-Balstilimab-Biologics-License-Application-to-the-U.S.-FDA-for-Patients-with-Recurrent-or-Metastatic-Cervical-Cancer-04-19-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Doses-First-Cancer-Patient-with-iNKT-Cell-Therapy-04-14-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/New-Clinical-Responses-for-AGEN1181-Presented-at-AACR-04-10-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-Webcast-Hosted-by-William-Blair-on-AGEN1181-and-Balstilimab-AACR-Presentations-04-06-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Corporate-Update-and-Fourth-Quarter-Full-Year-2020-Financial-Report-03-15-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Present-New-Clinical-Data-on-AGEN1181-at-AACR-2021-03-10-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Provide-Corporate-Update-and-Fourth-Quarter-Full-Year-2020-Financial-Report-03-02-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Andy-Hurley-Named-Agenus-Chief-Commercial-Officer-02-09-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Announces-Agenus-Insights-Virtual-RD-Miniseries-02-09-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Announces-New-Responses-for-AGEN1181-02-09-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Announces-Positive-Preliminary-Results-of-iNKT-Cell-Therapy-Trial-in-COVID-19-02-04-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-Enters-into-Clinical-Collaboration-with-Nelum-for-Zalifrelimab-Combination-01-26-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2021/Agenus-to-Participate-in-B.-Riley-Securities-Oncology-Investor-Conference-01-19-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Completion-of-Balstilimab-BLA-Filing-Extended-To-1H2021-12-03-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Launches-Phase-2-Trial-Expansion-in-Colon-Cancer-for-AGEN1181-in-Combination-with-Balstilimab-12-01-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Participate-in-Evercore-ISI-3rd-Annual-HealthCONx-Conference-11-25-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Participate-in-Fireside-Chat-at-the-Jefferies-2020-Virtual-London-Healthcare-Conference-11-16-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-and-Dr.-Steven-ODay-to-Participate-in-Webcast-Hosted-by-William-Blair-on-AGEN1181-and-SITC-Data-11-13-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-and-Dr.-Steven-ODay-to-Participate-in-Panels-at-the-Virtual-SITC-2020-Immuno-Oncology-Event-Hosted-by-B.-Riley-11-12-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/An-Agenus-discovered-first-in-class-ILT4-antibody-MK-4830-enters-Phase-2-11-10-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Presents-Additional-Clinical-Responses-and-Novel-Biomarker-Data-at-SITC2020-11-09-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Dr.-Steven-ODay-Named-Agenus-Chief-Medical-Officer-11-05-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Doses-First-COVID-19-Patient-with-iNKT-Cell-Therapy-11-02-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-RD-Update-Third-Quarter-Financial-Report-10-29-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Report-Third-Quarter-Earnings-10-20-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Present-on-Seven-Novel-Programs-at-SITC-2020-10-14-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Susan-Hirsch-Joins-Agenus-Board-of-Directors-10-13-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Initiates-Rolling-BLA-Submission-of-Balstilimab-for-RecurrentMetastatic-Cervical-Cancer-09-18-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Presents-Results-from-Two-Large-Cervical-Cancer-Trials-at-ESMO-09-18-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Dr.-Jennifer-Buell-Speaks-Live-at-Scientific-American-Inaugural-Fireside-Chat-Series-18-Minutes-With-09-17-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Participate-in-Webcast-Hosted-by-William-Blair-on-ESMO2020-Results-and-Novel-Pipeline-09-17-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Paul-Clark-Joins-Agenus-Board-of-Directors-08-31-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Announces-ESMO-Oral-Presentation-of-Two-Clinical-Trials-of-Balstilimab-Alone-and-in-Combination-with-Zalifrelimab-in-Recurrent-or-Metastatic-Cervical-Cancer-08-26-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Provides-RD-Update-Second-Quarter-Financial-Report-08-06-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Present-on-Targeting-Myeloid-Cells-in-Tumor-Microenvironment-at-the-William-Blair-Biotech-Focus-2020-Conference-08-04-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-RD-update-Second-Quarter-Earnings-Report-07-29-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Receives-35M-In-Immuno-Oncology-Transaction-with-Betta-Pharmaceuticals-07-28-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-To-Participate-in-a-Panel-on-Cell-Therapy-for-Infectious-Diseases-at-the-B.-Riley-Virtual-Infectious-Disease-Summit-07-21-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Cell-Therapy-and-Checkpoint-Antibody-Combinations-Show-Curative-Preclinical-Efficacy-at-AACR-2020-06-22-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-and-Betta-Pharmaceuticals-Enter-Into-a-License-Agreement-for-Balstilimab-and-Zalifrelimab-in-Greater-China-06-22-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-and-AgenTus-to-Participate-in-a-Panel-Presentation-on-Cell-Therapy-at-the-Raymond-James-Virtual-Human-Health-Innovation-Conference-06-17-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Present-at-the-Raymond-James-Virtual-Human-Health-Innovation-Conference-06-17-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Announces-Virtual-Annual-Shareholders-Meeting-06-16-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/FDA-Clears-IND-for-iNKT-Cells-to-Treat-COVID-19-Patients-06-02-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/ASCO-Presentation-of-Agenus-AGEN1181-by-Dr.-Steven-ODay-05-29-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-NextGen-CTLA-4-Antibody-AGEN1181-Data-to-be-Presented-at-ASCO-05-14-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/FDA-Clears-AgenTus-IND-for-Allogeneic-iNKT-Cell-Therapy-05-13-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-First-Quarter-Results-and-Update-05-07-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Report-First-Quarter-2020-Financial-Results-on-May-7-2020-and-Host-Conference-Call-and-Webcast-04-28-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Receives-Fast-Track-Designation-for-Balstilimab-in-Advanced-Cervical-Cancer-04-07-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Reports-Fourth-Quarter-and-Full-Year-2019-Financial-Results-and-Provides-Corporate-Update-03-12-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Receives-Fast-Track-Designation-for-Balstilimab-Zalifrelimab-in-Advanced-Cervical-Cancer-03-12-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/First-QS-21-Royalty-Payment-Due-to-Agenus-is-Triggered-03-10-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-to-Report-Fourth-Quarter-and-Full-Year-2019-Financial-Results-on-March-12-2020-with-Conference-Call-and-Webcast-03-03-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Announces-Positive-Interim-Data-from-Balstilimab-and-Zalifrelimab-Clinical-Trials-in-Second-Line-Cervical-Cancer-02-20-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Announces-Investor-Day-on-February-20-2020-02-06-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Announces-the-Appointment-of-Dr.-Jennifer-Buell-to-the-position-of-President-and-COO-01-09-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2020/Agenus-Commences-Phase-1-trial-with-AGEN1223-01-08-2020/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Commences-Combination-Trial-of-its-Next-Gen-CTLA-4-with-its-PD-1-Antibody-12-19-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Host-RD-Day-November-15-2019-11-12-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-receives-10M-from-UroGen-Pharma-for-rights-to-Zalifrelimab-CTLA-4-for-intravesical-treatment-of-urinary-tract-cancers-11-11-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Provides-Corporate-Update-with-Third-Quarter-2019-Financial-Results-11-04-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Report-Third-Quarter-2019-Financial-Results-on-November-4-2019-and-Host-Conference-Call-and-Webcast-10-31-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Present-at-the-2019-Cantor-Global-Healthcare-Conference-on-October-4-2019-09-30-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Triggers-3rd-Milestone-in-its-Collaboration-with-Gilead-08-28-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Manufacture-Clinical-Supply-of-GS-1423-for-Gilead-08-21-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Milestone-Triggers-7.5M-Payment-08-08-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Reports-Second-Quarter-2019-Financial-Results-and-Provides-Corporate-Update-08-08-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Report-Second-Quarter-2019-Financial-Results-on-August-8-2019-and-Host-Conference-Call-and-Webcast-08-06-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Appoints-Don-Vidic-as-Vice-President-and-Head-of-Commercial-07-18-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Host-Annual-Meeting-of-Stockholders-06-13-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Reports-First-Quarter-2019-Financial-Results-and-Provides-Corporate-Update-05-09-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Report-First-Quarter-2019-Financial-Results-on-May-9-2019-and-Host-Conference-Call-and-Webcast-05-03-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Begins-Dosing-with-Next-Gen-Anti-CTLA-4-Antibody-04-02-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Announces-Clinical-Appointments-03-21-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Reports-Fourth-Quarter-and-Full-Year-2018-Financial-Results-and-Provides-Corporate-Update-03-14-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Milestone-Triggers-7.5M-Payment-from-Gilead-03-13-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Report-Fourth-Quarter-and-Full-Year-2018-Financial-Results-on-March-14-2019-and-Host-Conference-Call-and-Webcast-03-08-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Launches-First-Asset-Backed-Digital-Security-Offering-in-Healthcare-02-19-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Host-Call-to-Launch-First-Asset-Backed-Digital-Security-Offering-in-Healthcare-on-February-19-2019-02-15-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-to-Launch-the-First-Asset-Backed-Digital-Security-Offering-in-Healthcare-01-29-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Closes-150-Million-Immuno-Oncology-Transaction-with-Gilead-01-24-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2019/Agenus-Awarded-Grant-to-Enable-QS-21-Innovations-01-03-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Gilead-And-Agenus-Enter-into-Collaboration-to-Develop-Immuno-Oncology-Therapies-12-20-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Elects-New-Board-Member-Dr.-Allison-Jeynes-Ellis-and-Appoints-Chief-Operating-Officer-Dr.-Jennifer-Buell-11-13-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Present-at-the-2018-Jefferies-London-Healthcare-Conference-11-13-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Present-Data-on-Neoantigen-Vaccines-and-anti-CD137-Antibody-at-SITC-2018-11-06-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Reports-Third-Quarter-2018-Financial-Results-and-Provides-Corporate-Update-11-06-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Report-Third-Quarter-2018-Financial-Results-on-November-6-2018-and-Host-Conference-Call-and-Webcast-10-31-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Presents-Clinical-Data-on-Its-PD-1-CTLA-4-at-ESMO-2018-10-20-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-To-Present-Data-on-Proprietary-CTLA-4-PD-1-Antibodies-at-ESMO-2018-10-09-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Present-at-the-2018-Cantor-Fitzgerald-Global-Healthcare-Conference-in-New-York-NY-09-28-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Closes-15-Million-Partial-Royalty-Monetization-With-XOMA-09-21-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Receives-Milestone-Payment-from-Incyte-09-17-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/AgenTus-Therapeutics-to-Present-on-the-Anti-tumor-Activities-of-Two-Proprietary-T-Cell-Receptors-TCRs-at-CAR-TCR-Summit-in-Boston-MA-09-05-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Present-at-The-Annual-B.-Riley-FBR-Healthcare-Conference-in-New-York-City-09-04-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Receives-Second-Milestone-Payment-from-Merck-08-15-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Reports-Second-Quarter-2018-Financial-Results-and-Provides-Corporate-Update-08-09-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Report-Second-Quarter-2018-Financial-Results-on-August-9-2018-and-Host-Conference-Call-and-Webcast-08-02-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Appoints-Regulatory-and-Clinical-Heads-07-16-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Webcast-Annual-Meeting-of-Stockholders-06-20-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Discovery-Enhances-Activity-of-Cancer-Fighting-Antibodies-Findings-Published-in-Cancer-Cell-06-12-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Present-at-the-Jefferies-2018-Global-Healthcare-Conference-in-New-York-NY-06-06-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Presents-Clinical-Responses-of-AGEN1884-anti-CTLA-4-and-AGEN2034-anti-PD-1-at-ASCO-2018-06-04-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Present-Clinical-Data-on-Lead-Programs-at-ASCO-2018-05-17-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Reports-First-Quarter-2018-Financial-Results-and-Provides-Corporate-Update-05-07-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Present-at-Deutsche-Banks-43rd-Annual-Health-Care-Conference-in-Boston-05-07-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Report-First-Quarter-2018-Financial-Results-on-May-7-2018-and-Host-Conference-Call-and-Webcast-05-03-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/AgenTus-Therapeutics-to-Present-on-Novel-TCR-Platform-and-Progress-at-PEGS-Summit-in-Boston-MA-05-01-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Three-Agenus-Abstracts-Accepted-for-Presentation-at-the-American-Association-for-Cancer-Research-AACR-2018-Annual-Meeting-04-11-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Present-at-Healthcare-Investor-Conferences-In-April-03-29-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Reports-Fourth-Quarter-and-Full-Year-2017-Financial-Results-and-Provides-Corporate-Update-03-15-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-to-Report-Fourth-Quarter-and-Full-Year-2017-Financial-Results-on-March-15-2018-and-Host-Conference-Call-and-Webcast-03-07-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Announces-Combination-Clinical-Trials-of-its-Anti-CTLA4-AGEN1884-Anti-PD1-AGEN2034-01-22-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Inc.-Announces-230-Million-Royalty-Monetization-with-HealthCare-Royalty-Partners-01-08-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Dr.-John-Castle-Joins-Thought-Leadership-Panel-on-I-O-Combinations-at-10th-Annual-Biotech-Showcase-2018-01-04-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2018/Agenus-Announces-Key-Leadership-to-Advance-Combination-Trials-For-Planned-BLA-Filings-01-03-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-Receives-License-Fee-of-4-Million-USD-from-Merck-11-15-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-To-Present-on-Lead-Antibody-Programs-AGEN1884-CTLA-4-and-AGEN2034-PD-1-at-SITC-2017-11-09-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Present-at-the-Jefferies-Global-Healthcare-Conference-in-London-11-08-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-Reports-Third-Quarter-2017-Financial-Results-and-Provides-Corporate-Update-11-07-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Report-Third-Quarter-2017-Financial-Results-on-November-7-2017-and-Host-Conference-Call-and-Webcast-10-26-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Shingrix-with-QS-21-Stimulon-Receives-Positive-Recommendation-from-CDCs-Advisory-Committee-on-Immunization-Practices-as-Preferred-Vaccine-for-Prevention-of-Shingles-10-25-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Bruno-Lucidi-Appointed-Chief-Executive-Officer-of-AgenTus-Therapeutics-The-Cell-Therapy-Subsidiary-of-Agenus-10-23-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-creates-New-Cell-Therapy-subsidiary-named-AgenTus-Therapeutics-10-23-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/FDA-Approves-GSKs-Shingles-Vaccine-with-Agenus-QS-21-Stimulon-Adjuvant-10-20-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/GSKs-Shingrix-Containing-Agenus-QS-21-Stimulon-Adjuvant-Receives-Marketing-Authorization-from-Health-Canada-10-13-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Present-at-Two-Healthcare-Investor-Conferences-In-September-09-19-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/GSKs-Shingrix-containing-Agenus-QS-21-Stimulon-adjuvant-receives-Unanimous-FDA-Advisory-Committee-recommendation-for-approval-09-13-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-Reports-Second-Quarter-2017-Financial-Results-and-Provides-Corporate-Update-08-03-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Report-Second-Quarter-2017-Financial-Results-on-August-3-2017-Conference-Call-to-Follow-07-27-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Webcast-Annual-Meeting-of-Stockholders-06-21-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Positive-Phase-3-for-GSKs-shingles-vaccine-Shingrix-with-Agenus-QS-21-Stimulon-immune-adjuvant-06-21-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-anti-CTLA-4-antibody-shows-strong-safety-and-tolerability-06-05-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Participate-at-Two-Upcoming-Conferences-in-New-York-City-Jefferies-Healthcare-and-JMP-Securities-Life-Sciences-06-01-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-present-safety-results-for-anti-CTLA-4-antibody-at-ASCO-2017-Annual-Meeting-05-22-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-Reports-First-Quarter-2017-Financial-Results-and-Provides-Corporate-Update-05-04-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Report-First-Quarter-2017-Financial-Results-on-May-4-2017-Conference-Call-to-Follow-04-27-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Phase-12-Clinical-Trial-of-Agenus-anti-PD-1-Antibody-Begins-04-20-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-Commences-Phase-1-Trial-with-Neoantigen-Cancer-Vaccine-AutoSynVax-04-05-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-Restructures-Business-to-Sharpen-Focus-on-Clinical-Development-of-Cancer-Therapies-03-30-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Participate-at-Two-Upcoming-Immuno-Oncology-Conferences-03-24-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-Reports-Fourth-Quarter-and-Full-Year-2016-Results-03-09-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Four-Agenus-Abstracts-Accepted-for-Presentation-at-the-American-Association-for-Cancer-Research-AACR-2017-Annual-Meeting-03-07-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-to-Report-Fourth-Quarter-and-Year-End-2016-Financial-Results-on-March-9-2017-Conference-Call-to-Follow-03-02-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Incyte-and-Agenus-Amend-Collaboration-Agreement-02-14-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-Appoints-Jean-Marie-Cuillerot-M.D.-Chief-Medical-Officer-01-30-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2017/Agenus-announces-collaboration-with-the-National-Cancer-Institute-to-evaluate-the-combination-of-Pembrolizumab-Keytruda-Merck-Co.-Inc.-with-Prophage-Agenus-Inc.-autologous-vaccine-01-17-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Announces-Commencement-of-Phase-12-Clinical-Trial-of-anti-OX40-Checkpoint-Antibody-INCAGN1949-in-Patients-with-Solid-Tumors-11-30-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Present-at-the-Jefferies-2016-London-Healthcare-Conference-11-14-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Reports-Third-Quarter-Financial-Results-and-Recent-Highlights-10-27-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Report-Third-Quarter-2016-Financial-Results-on-October-27-2016-Conference-Call-to-Follow-10-20-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Appoints-James-Gorman-M.D.-Ph.D.-as-Vice-President-of-Strategic-Planning-and-Portfolio-Management-10-18-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Present-at-the-Rodman-Renshaw-18th-Annual-Global-Investment-Conference-09-06-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Reports-Second-Quarter-2016-Financial-Results-and-Operational-Progress-07-28-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Report-Second-Quarter-2016-Financial-Results-on-July-28-2016-Conference-Call-to-Follow-07-21-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Appoints-Jean-Marie-Cuillerot-M.D.-as-Vice-President-and-Global-Head-of-Clinical-Development-07-06-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Announces-Commencement-of-Phase-12-Clinical-Trial-of-anti-GITR-Checkpoint-Antibody-INCAGN1876-in-Patients-with-Solid-Tumors-06-22-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Present-at-the-2016-JMP-Securities-Life-Sciences-Conference-06-15-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Announces-Lead-Product-Candidate-Selection-in-its-Collaboration-with-Merck-06-09-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Webcast-Annual-Meeting-of-Stockholders-06-08-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Present-at-the-Jefferies-2016-Healthcare-Conference-06-02-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Appoints-Ulf-Wiinberg-to-Board-of-Directors-05-19-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Reports-First-Quarter-2016-Financial-Results-and-Operational-Progress-04-28-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Commences-Phase-1-Clinical-Trial-of-its-CTLA-4-Checkpoint-Antibody-to-Treat-Solid-Tumors-04-27-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Report-First-Quarter-2016-Financial-Results-on-April-28-2016-Conference-Call-to-Follow-04-21-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Presents-Posters-on-Checkpoint-Antibody-Product-Candidates-at-the-American-Association-for-Cancer-Research-AACR-2016-Annual-Meeting-04-18-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Participate-at-Three-Upcoming-Oncology-Conferences-03-30-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Reports-Fourth-Quarter-and-Full-Year-2015-Financial-and-Operational-Results-and-Recent-Highlights-03-03-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Present-at-the-Cowen-and-Company-36th-Annual-Health-Care-Conference-03-01-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-to-Report-Fourth-Quarter-and-Year-End-2015-Financial-Results-on-March-3-2016-Conference-Call-to-Follow-02-25-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Announces-Clearance-of-Investigational-New-Drug-Applications-by-the-FDA-for-anti-CTLA-4-and-anti-GITR-Antibodies-01-21-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635c4-01-14-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2016/Agenus-Completes-XOMA-Antibody-Manufacturing-Pilot-Plant-Acquisition-01-04-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Acquires-PhosImmune-with-a-Novel-Class-of-Cancer-Neoantigens-12-23-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Present-at-the-Oppenheimer-26th-Annual-Healthcare-Conference-12-01-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-RD-Update-to-Be-Held-on-November-19-2015-11-12-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Acquire-Antibody-Manufacturing-Capability-Expands-Antibody-Discovery-and-adds-Cell-Line-Development-Capabilities-with-Three-Separate-Transactions-11-05-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Reports-Third-Quarter-2015-Financial-Results-10-27-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/GSKs-candidate-Shingles-Vaccine-Containing-Agenus-QS-21-Stimulon-Demonstrates-90-Efficacy-against-Shingles-and-89-Efficacy-against-Post-Herpetic-Neuralgia-in-Adults-aged-70-Years-and-Older-10-27-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Report-Third-Quarter-2015-Financial-Results-on-October-27-2015-Conference-Call-to-Follow-10-20-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Inc.-Completes-115-Million-Non-Dilutive-Royalty-Transaction-with-Oberland-Capital-09-09-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Present-at-the-Rodman-Renshaw-17th-Annual-Global-Investment-Conference-09-08-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/GSKs-Malaria-Vaccine-Containing-Agenus-QS-21-Stimulon-Receives-Positive-Opinion-from-European-Regulators-for-Prevention-of-Malaria-in-Young-Children-in-Sub-Saharan-Africa-07-24-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Reports-Second-Quarter-2015-Financial-Results-07-23-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Acquires-Novel-Antibodies-to-Immuno-oncology-Target-CEACAM1-07-20-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Report-Second-Quarter-2015-Financial-Results-on-July-23-2015-Conference-Call-to-Follow-07-16-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Webcast-Annual-Meeting-of-Stockholders-06-22-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Present-at-the-2015-JMP-Securities-Life-Sciences-Conference-06-18-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Appoints-C.-Evan-Ballantyne-as-Chief-Financial-Officer-06-17-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Merck-Extends-Immuno-Oncology-Collaboration-with-Agenus-06-03-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Updated-Phase-2-Data-of-Prophage-In-Newly-Diagnosed-GBM-Presented-at-ASCO-Show-Improvement-in-Median-Progression-Free-Survival-and-Overall-Survival-Independently-of-Prognostic-Markers-Compared-with-Historical-Expectations-06-01-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Present-at-the-Jefferies-2015-Healthcare-Conference-05-28-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Announces-Closing-of-Public-Offering-and-Exercise-in-Full-of-Underwriters-Option-to-Purchase-Additional-Shares-of-Common-Stock-05-27-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Announces-Proposed-Public-Offering-of-Common-Stock-05-21-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Announces-Pricing-of-Its-Public-Offering-of-Common-Stock-05-21-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Announces-Oral-Presentation-at-ASCO-Highlighting-Improved-Survival-with-Prophage-Immunotherapy-in-Brain-Cancer-Compared-to-Historical-Controls-05-14-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Host-Research-and-Development-Day-on-May-14-2015-05-08-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/NEJM-Publishes-Study-Showing-GSKs-Shingles-Vaccine-Containing-Agenus-QS-21-Stimulon-Adjuvant-Provides-over-97-Protection-in-People-Over-the-Age-of-50-04-28-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/GSKs-Malaria-Vaccine-Phase-3-Study-Containing-Agenus-QS-21-Published-in-The-Lancet-04-24-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Reports-First-Quarter-2015-Financial-Results-04-23-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Report-First-Quarter-2015-Financial-Results-on-April-23-2015-Conference-Call-to-Follow-04-20-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Acquires-Celexion-Assets-and-Expands-Its-Antibody-Discovery-Platform-04-08-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-Reports-Fourth-Quarter-and-Full-Year-2014-Financial-Results-02-26-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Present-at-the-Cowen-and-Company-35th-Annual-Health-Care-Conference-02-25-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Report-Fourth-Quarter-and-Year-End-2014-Financial-Results-on-February-26-2015-Conference-Call-to-Follow-02-20-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Present-at-the-17th-Annual-BIO-CEO-Investor-Conference-02-03-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Agenus-to-Host-Conference-Call-to-Discuss-Global-Alliance-with-Incyte-Corporation-Today-at-830-a.m.-EST-01-09-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2015/Incyte-and-Agenus-Announce-Global-Alliance-to-Develop-Novel-Immuno-Oncology-Antibodies-01-09-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Positive-Outcome-of-Phase-3-Study-of-GSK-Shingles-Vaccine-Containing-Agenus-Adjuvant-12-18-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Reports-Third-Quarter-2014-Financial-Results-10-31-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Report-Third-Quarter-2014-Financial-Results-on-October-31-2014-Conference-Call-to-Follow-10-27-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Participate-in-Two-Upcoming-Investor-Conferences-09-02-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Present-at-Cambridge-Healthtech-Institutes-Second-Annual-Conference-on-Immunomodulatory-Therapeutic-Antibodies-for-Cancer-08-04-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Reports-Second-Quarter-2014-Financial-Results-07-24-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/First-Vaccine-Candidate-for-Malaria-is-Accepted-for-EU-Regulatory-Review-07-24-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Report-Second-Quarter-2014-Financial-Results-on-July-24-2014-Conference-Call-to-Follow-07-17-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Brain-Cancer-Vaccine-Shows-Extended-Survival-in-Phase-2-Final-Data-Analysis-07-01-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Vaccine-Shows-Significant-Reduction-in-Viral-Burden-after-HerpV-Generated-Immune-Activation-06-26-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Present-at-the-JMP-Securities-Healthcare-Conference-06-19-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Selected-for-Inclusion-in-the-Russell-3000-Index-and-Global-Index-06-16-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Present-at-Jefferies-2014-Global-Healthcare-Conference-05-30-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Reports-First-Quarter-2014-Financial-Results-05-08-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Report-First-Quarter-2014-Financial-Results-on-May-8-2014-Conference-Call-to-Follow-04-29-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Announces-Collaboration-and-License-Agreement-with-Merck-for-Novel-Checkpoint-Antibody-Based-Cancer-Immunotherapies-04-28-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Host-Annual-Meeting-of-Stockholders-04-16-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Update-On-GSKS-MAGE-A3-Cancer-Immunotherapeutic-Phase-3-Study-in-Non-Small-Cell-Lung-Cancer-04-02-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Present-at-the-4th-Annual-Cancer-Immunotherapy-Conference-03-26-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/GSKs-MAGE-A3-Cancer-Immunotherapeutic-Phase-3-Study-in-Non-small-Cell-Lung-Cancer-Misses-First-Co-primary-Endpoints-03-20-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Reports-Fourth-Quarter-and-Full-Year-2013-Financial-Results-03-05-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-To-Advance-Three-Checkpoint-Modulator-Antibodies-Into-Development-03-05-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Report-Fourth-Quarter-and-Year-End-2013-Financial-Results-on-March-5-2014-Conference-Call-to-Follow-02-27-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Completes-Acquisition-of-4-Antibody-02-13-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Announces-Closing-of-Public-Offering-and-Exercise-of-Over-Allotment-Option-02-10-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-to-Present-at-BIO-CEO-Investor-Conference-02-06-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Prices-Public-Offering-of-Common-Stock-02-05-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Prophage-Vaccine-for-Glioma-Hailed-As-a-Very-Promising-Therapy-in-an-Editorial-Published-in-the-Journal-Neuro-Oncology-01-21-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Announces-Phase-2-Checkpoint-inhibitor-Combination-Trial-with-Prophage-Cancer-Vaccine-for-Melanoma-01-14-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Enters-into-Definitive-Agreement-to-Acquire-Privately-Held-4-Antibody-AG-01-13-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2014/Agenus-Appoints-Robert-B.-Stein-MD-PhD-as-Chief-Scientific-Officer-01-13-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Positive-Phase-2-Results-from-Agenus-Brain-Cancer-Vaccine-Published-in-Neuro-Oncology-12-16-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Brain-Cancer-Vaccine-Program-Named-a-Top-Project-to-Watch-by-Elsevier-Business-Intelligence-11-18-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-HerpV-Therapeutic-Vaccine-for-Genital-Herpes-Meets-Primary-Endpoint-in-Randomized-Phase-2-Trial-11-07-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Reports-Third-Quarter-2013-Financial-Results-10-24-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Report-Third-Quarter-2013-Financial-Results-on-October-24-2013-Conference-Call-to-Follow-10-16-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/GSKs-Vaccine-Candidate-Containing-Agenus-QS-21-Stimulon-Reduces-Malaria-Infection-in-Phase-3-Trials-of-Over-15000-Children-10-07-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-and-Vaxlogic-LLC-Execute-QS-21-Stimulon-Adjuvant-Licensing-Agreement-for-Addiction-Allergy-and-Respiratory-Vaccines-09-26-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Completes-Registered-Direct-Offering-09-23-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Completes-Registered-Direct-Offering-09-19-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Announces-6.5-Million-Registered-Direct-At-the-Market-Offering-09-18-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Participate-in-Brain-Cancer-Vaccine-and-Immunotherapy-Discussion-on-September-23rd-Webcast-09-18-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Reports-Positive-Follow-on-Phase-2-Results-for-Brain-Cancer-Vaccine-in-Newly-Diagnosed-Patients-09-17-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/GSKS-MAGE-A3-Cancer-Immunotherapeutic-Phase-3-Study-in-Melanoma-Misses-First-Co-Primary-Endpoint-09-05-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Present-at-two-Upcoming-Healthcare-Conferences-Upcoming-Healthcare-Conferences-09-04-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Reports-Second-Quarter-2013-Financial-Results-07-25-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Report-Second-Quarter-2013-Financial-Results-on-July-25-2013-Conference-Call-to-Follow-07-18-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Present-at-the-JMP-Securities-Annual-Healthcare-Conference-07-02-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Webcast-Annual-Shareholders-Meeting-06-10-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Announces-Initiation-of-Enrollment-in-NCI-Sponsored-Randomized-Trial-of-Prophage-G-200-Vaccine-with-Avastin-in-Treatment-of-Brain-Tumors-05-22-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Reports-First-Quarter-2013-Financial-Results-04-24-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Report-First-Quarter-2013-Financial-Results-on-April-24-2013-Conference-Call-to-Follow-04-18-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Brain-Cancer-Vaccine-Results-to-be-Presented-at-Plenary-Session-of-the-81st-American-Association-of-Neurological-Surgeons-AANS-Annual-Scientific-Meeting-04-10-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Present-at-the-ROTH-Annual-Conference-03-04-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-Reports-Fourth-Quarter-and-Year-End-2012-Financial-Results-02-28-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-HerpV-Phase-2-Study-to-Treat-Genital-Herpes-Completes-Enrollment-02-27-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Present-at-Cowen-and-Company-Annual-Healthcare-Conference-02-26-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/news-details/2013/Agenus-to-Report-Fourth-Quarter-and-Year-End-2012-Financial-Results-on-February-28-2013-Conference-Call-to-Follow-02-21-2013/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:48:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=ebbc948f-8aa5-4994-bff5-9c004aaab4d0</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-04-09T11:34:07-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=ed8f2d4a-2958-490c-b842-cbc74641b5b9</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-04-09T11:34:07-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=addfa9db-77a0-495c-b3bf-06ba804a4613</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-07-25T08:00:08-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=aff4caba-2eb8-4c16-80fd-1f9c93ea514b</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-17T10:18:27-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=c803fc4c-17d3-4377-b87b-7391d42ba574</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-17T10:18:27-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=0138f103-589f-49ec-8cae-bbee8e97adcd</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-17T10:18:27-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=dbfa27b3-0439-4d07-b282-dea8ae69c1bf</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-17T10:18:27-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=56258081-c878-4c8c-b418-9b85b7d932be</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-17T10:18:27-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=dc30320b-9a7b-4479-bb9f-35ae2fa7f4d1</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-11-19T02:27:34-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/person-details/default.aspx?ItemId=08d89de4-b2c5-48cf-82eb-6a983c81ab2e</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2026-11-19T02:27:34-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/overview/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T01:28:32-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/news/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-11T02:21:02-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/events-and-presentations/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-23T10:47:47-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/governance/governance-documents/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2018-07-03T11:42:31-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/financial-information/quarterly-results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-12-26T12:48:26-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/financial-information/annual-reports/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-12-26T12:48:26-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/resources/information-request-form/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T09:37:41-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/resources/investor-email-alerts/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-12-26T12:51:54-05:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/resources/investor-contacts/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-02T12:00:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/governance/committee-composition/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-31T10:36:30-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/financial-information/sec-filings/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-10T03:43:28-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/financial-information/stock-info/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-10T03:43:28-04:00</lastmod>
  </url>
  <url>
    <loc>https://investor.agenusbio.com/financial-information/analyst-coverage/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-28T04:37:07-04:00</lastmod>
  </url>
</urlset>